Published in Women's Health Weekly, January 10th, 2002
The FDA determined that Perrigo's tioconazole ointment, 6.5%, is bioequivalent to Bristol-Myers Squibb's Vagistat-1, marketed for the treatment of vaginal yeast infections. The FDA also concluded that Perrigo's migraine formula tablet containing acetaminophen 250 mg, aspirin 250 mg, and caffeine 65 mg is bioequivalent to Bristol-Myers Squibb's Excedrin Migraine.
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly